ZP
FUSN

Zimmer Partners’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Zimmer Partners’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-22,500
Closed -$393K – 164
2020
Q2 		$393K Buy
+22,500
New +$392K 0.01% 105

Other funds holding FUSN

JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Zimmer Partners's FUSN Position: Q3 2020 in Review

Zimmer Partners sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q3 2020, closing a stake of 22,500 shares — an estimated $393K sold.

Zimmer Partners first reported a position in FUSN in Q2 2020 and held it in 1 quarter. The position peaked at $393K in Q2 2020. 29 funds tracked by Wall St. Rank hold FUSN as of Q3 2020.

  • Zimmer Partners reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q3 2020 after selling out during the quarter.
  • Zimmer Partners sold 22,500 Fusion Pharmaceuticals Inc. Common Shares shares in Q3 2020, an estimated $393K.
  • Zimmer Partners first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 1 quarter.
  • Zimmer Partners's Fusion Pharmaceuticals Inc. Common Shares position peaked at $393K in Q2 2020.
  • 29 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q3 2020.

Based on Zimmer Partners's 13F filing for Q3 2020, filed 16 Nov 2020.